BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 21523522)

  • 21. [Different sensitivity to chemotherapy between adenocarcinoma and adenosquamous carcinoma in a case of synchronous multicentric gastric cancer].
    Watanabe K; Achiwa K; Muto H; Arakawa N; Aoki K; Kubota M; Ishikawa D; Kunii S; Goto K; Okumura A
    Nihon Shokakibyo Gakkai Zasshi; 2012 Mar; 109(3):408-17. PubMed ID: 22398906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High activity and low toxicity of a novel CD71-targeting nanotherapeutic named The-0504 on preclinical models of several human aggressive tumors.
    Falvo E; Damiani V; Conti G; Boschi F; Messana K; Giacomini P; Milella M; De Laurenzi V; Morea V; Sala G; Fracasso G; Ceci P
    J Exp Clin Cancer Res; 2021 Feb; 40(1):63. PubMed ID: 33568214
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comprehensive Cell Surface Antigen Analysis Identifies Transferrin Receptor Protein-1 (CD71) as a Negative Selection Marker for Human Neuronal Cells.
    Menon V; Thomas R; Elgueta C; Horl M; Osborn T; Hallett PJ; Bartos M; Isacson O; Pruszak J
    Stem Cells; 2019 Oct; 37(10):1293-1306. PubMed ID: 31381839
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Selection and identification of transferrin receptor-specific peptides as recognition probes for cancer cells.
    Tan Y; Liu W; Zhu Z; Lang L; Wang J; Huang M; Zhang M; Yang C
    Anal Bioanal Chem; 2018 Jan; 410(3):1071-1077. PubMed ID: 29046922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CD71 in Gestational Pathology: A Versatile Immunohistochemical Marker With New Possible Applications.
    Luchini C; Parcesepe P; Nottegar A; Parolini C; Mafficini A; Remo A; Chilosi M; Manfrin E
    Appl Immunohistochem Mol Morphol; 2016 Mar; 24(3):215-20. PubMed ID: 25906120
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Affinity separation and subsequent terminal differentiation of acute myeloid leukemia cells using the human transferrin receptor (CD71) as a capture target.
    Lyons VJ; Pappas D
    Analyst; 2019 May; 144(10):3369-3380. PubMed ID: 30984961
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protease sensitivity and redistribution of CD71 and glycophorin A on K562 cells.
    Yu CH; Wang H; Wang Y; Cui NX; Zhao X; Rong L; Yi ZC
    Cell Mol Biol (Noisy-le-grand); 2017 Sep; 63(9):40-45. PubMed ID: 28980921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neglected Cells: Immunomodulatory Roles of CD71
    Elahi S
    Trends Immunol; 2019 Mar; 40(3):181-185. PubMed ID: 30718046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Elucidation and Structural Modeling of CD71 as a Molecular Target for Cell-Specific Aptamer Binding.
    Wu X; Liu H; Han D; Peng B; Zhang H; Zhang L; Li J; Liu J; Cui C; Fang S; Li M; Ye M; Tan W
    J Am Chem Soc; 2019 Jul; 141(27):10760-10769. PubMed ID: 31185171
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adenosquamous gastric carcinoma in Caucasian patient.
    Blázquez S; Raventós A; Díaz ML; García-Fontgivell JF; Martínez S; Sirvent JJ
    Rev Esp Enferm Dig; 2005 Mar; 97(3):211-2. PubMed ID: 15839815
    [No Abstract]   [Full Text] [Related]  

  • 31. Understanding gastric adenosquamous cell carcinoma: Insights from immunoprofiling.
    Liu CY
    J Chin Med Assoc; 2023 Sep; 86(9):780. PubMed ID: 37466665
    [No Abstract]   [Full Text] [Related]  

  • 32. Internalization of transferrin-tagged
    Gabashvili AN; Alexandrushkina NA; Mochalova EN; Goliusova DV; Sapozhnikova EN; Makarevich PI; Nikitin PI
    Exp Biol Med (Maywood); 2024; 249():10055. PubMed ID: 38774281
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpressed transferrin receptor implied poor prognosis and relapse in gastrointestinal stromal tumors.
    Zhuang C; Li X; Yang L; Ma X; Shen Y; Huang C; Pan T; Cui J; Ni B; Wang M
    Front Oncol; 2023; 13():1151687. PubMed ID: 37675227
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The origin of gastric cancer stem cells and their effects on gastric cancer: Novel therapeutic targets for gastric cancer.
    Yang Y; Meng WJ; Wang ZQ
    Front Oncol; 2022; 12():960539. PubMed ID: 36185219
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cancer Stem Cells: From an Insight into the Basics to Recent Advances and Therapeutic Targeting.
    Bisht S; Nigam M; Kunjwal SS; Sergey P; Mishra AP; Sharifi-Rad J
    Stem Cells Int; 2022; 2022():9653244. PubMed ID: 35800881
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular mechanism of therapeutic approaches for human gastric cancer stem cells.
    Hsieh HL; Yu MC; Cheng LC; Yeh TS; Tsai MM
    World J Stem Cells; 2022 Jan; 14(1):76-91. PubMed ID: 35126829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cancer Stem Cells and the Tumor Microenvironment in Gastric Cancer.
    Yang Y; Meng WJ; Wang ZQ
    Front Oncol; 2021; 11():803974. PubMed ID: 35047411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human Gastric Cancer Stem Cell (GCSC) Markers Are Prognostic Factors Correlated With Immune Infiltration of Gastric Cancer.
    Lin T; Peng W; Mai P; Zhang E; Peng L
    Front Mol Biosci; 2021; 8():626966. PubMed ID: 34113647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Store-Operated Calcium Channels as Drug Target in Gastroesophageal Cancers.
    Chang Y; Roy S; Pan Z
    Front Pharmacol; 2021; 12():668730. PubMed ID: 34012400
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies.
    Guo Z; Zhang Y; Fu M; Zhao L; Wang Z; Xu Z; Zhu H; Lan X; Shen G; He Y; Lei P
    Front Immunol; 2021; 12():652924. PubMed ID: 33854512
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.